Novartis Smart Inhaler
Novartis is a large multinational pharmaceutical company
This project developed a smart inhaler. It contained a powerful microprocessor, sensors and a miniature transducer to atomise the powder to the air. Smart inhalers have a number of advantages over 'passive' hand-actuated mechanical devices or aerosol devices.
(not actual design)
Reduced misuse,
Both aerosol and dry power inhalers require instruction in their use and coordination between hand and breath. Inevitably this can lead to an inappropriate dose. In some cases there can be damage to the throat and mouth.
​
Better Development data
Since real usage data can be stored and collected, it is easier to verify the effectiveness of the drug being used. This leads to quicker and cheaper drug development. A passive system will rely on user records.
Remote monitoring
Since useage can be monitored remotely, less time is required with physicians which means more patients can be treated.
​
Active User feedback
An integrated display can provide user feedback and dosage information. This can help patients to stick to the dosage schedule and makes for an easier user experience.
​